Application of FAM172A autoantibody detection reagent in preparing lung cancer screening kit

A technology of FAM172A and autoantibodies, which is applied in biological testing, measuring devices, material inspection products, etc., can solve the problems of no FAM172A protein and no lung cancer, and achieve good application prospects, low patient harm, and effective screening Check the effect
CN110108877AActive Publication Date: 2019-08-09WEST CHINA HOSPITAL SICHUAN UNIV
4 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
WEST CHINA HOSPITAL SICHUAN UNIV
Publication Date
2019-08-09

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of in vitro diagnostic reagents, and particularly relates to an application of an FAM172A autoantibody detection reagent in preparing a lung cancer screening kit. The scheme of the invention finds for the first time that the autoantibody level of FAM172A protein in the serum of lung cancer patients is significantly higher than that of healthy patients. The schemeof the invention uses a reagent for detecting an FAM172A protein autoantibody to prepare the lung cancer screening kit, and can realize the effective screening of lung cancer.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of in vitro diagnostic reagents, in particular to the use of FAM172A autoantibody detection reagents in the preparation of lung cancer screening kits. Background technique

[0002] Lung cancer is one of the most common malignant tumors in the world. Its morbidity and mortality are increasing year by year. Currently, the incidence rate ranks first in the world, which seriously threatens human health and life.

[0003] Lung cancer is a disease that is good at concealment. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they are diagnosed with lung cancer symptoms. The best cure time, five-year survival rate is low. For patients with early lung cancer, timely treatment can greatly improve the 5-year survival rate and quality of life of the patients. Therefore, early diagnosis and effective screening of lung canc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More